RA is thought to be caused by a combination of genetic and environmental factors. There is a well recorded association between RA and HLA-DR4 in most populations studied' and a weaker association between RA and the immunoglobulin heavy chain constant region allotype, Glm(x), in DR4 positive disease only, suggesting that genes linked to HLA on chromosome 6 and to Gm on chromosome 14 may interact in disease predisposition.23
A subgroup of patients with RA accounting for about 11% of RA patients seen in hospital has been shown to have circulating antibodies to native type II collagen and shows an association with HLA-DR3 or DR7 rather than DR4.4 Apart from a decreased frequency of seropositivity for rheumatoid factor and a later age of disease onset these patients are clinically indistinguishable The aim of this study therefore was to reinvestigate the relation between RA and Gm in a larger group of patients who had been tested for the presence of circulating antibodies to native type II collagen and to look for evidence of an interaction between HLA and Gm in this disease subset.
Patients and methods
One hundred and sixty six patients with classical or definite RA (by American Rheumatism Association criteria"') were studied. These were all unrelated Caucasians and were attending rheumatology outpatient clinics at Manchester Royal Infirmary I.)i 15 normal sera with each batch tested (these results did not differ significantly from those obtained using a larger group of 100 normal sera). Results greater than two standard deviations above the mean were considered to be positive. HLA typing was carried out for A and B antigens using standard National Institute of Health methods. HLA-DR typing was carried out using B lymphocytes isolated by their adherence to nylon wool columns. All antisera were obtained locally or through mutual exchange with other laboratories and characterised using cell panels typed with international histocompatibility antisera.
Gm and Km allotyping was performed by the technique of haemagglutination inhibition.' The following allotypes were recognised: Glm(z, a, x, f), G2m(n), G3m(bO, bl, b3, b5, g, s, t, c3, c5), Km(1) and (3). G3m (bO, bl, b3, and b5) always occurred together and are henceforth referred to simply as G3m(b).
S T A T I S T I C S
Results were analysed using a x2 test or Fisher's exact test. Table 1 shows the distribution of Gm phenotypes in collagen antibody positive and negative patient groups and in controls. The Gm(zafngb) phenotype was increased in the collagen antibody positive RA patients when compared with collagen antibody negative RA (p=00093). As the phenotype Gm([z]afgb) has been previously reported to be associated with collagen antibody positive RA9 in a study in which the G2m(n) allotype was not tested for, there is a priori evidence to suggest that phenotypes Gm(zafngb) or Gm(zafgb) may be implicated in this type of RA so that the p value need not be corrected for the total number of phenotypes compared.'3 Table 2 shows the distribution of Gm and Km allotypes in the two patient groups and controls. There were no significant differences in frequency between the groups for Gm allotypes. Km(1) was increased in the collagen antibody negative RA group compared with the controls, but the difference did not reach statistical significance after correction of the p value (which is necessary as there Km(l) 20.5* is no a priori association of RA with Km allotypes).
Results
In Table 3 we examine the possibility of an interaction between HLA and Gm in collagen antibody positive RA and show the relative frequencies of HLA-DR4, DR3, and DR7 in the patient groups. As expected there was a strong association between collagen antibody negative RA and HLA-DR4 and as previously shown an association between RA and Glm(x) bearing haplotypes in DR4 positive disease only.3 The collagen antibody positive subgroup was significantly associated with In Table 4 we consider the relative risks for HLA and Gm linked markers found in association with the respective patient groups. The relative risks for HLA-DR3/7, Gm(zafngb), and the combination of these markers were significantly higher in the collagen antibody positive than in the collagen antibody negative RA group. Although there are trends with this method of analysis for interactions between HLA-DR3/7 or DR4 and the Gm(zafngb) phenotype or Glm(x) allotype in collagen antibody positive and negative RA groups respectively, the 95% confidence limits for the combinations of markers overlapped with those for HLA and Gm linked markers alone.
In the above search for an interaction between HLA and Gm the numbers of collagen antibody positive patients were relatively small. In Table 5 , therefore, we have looked for evidence of an interaction between HLA-DR3/7 and the Gm(zafngb) phenotype in the RA population overall and irrespective of collagen antibody status. As shown there was a statistically significant increase in frequency of this Gm phenotype in DR3 and DR7 positive RA patients.
Discussion
In previous studies a subgroup of patients with RA characterised by persisting antibodies to native type II collagen was shown to have an HLA association with HLA-DR3 or DR7 rather than with HLA-DR4, the DR antigen associated with RA patients overall.4 5 The antigens HLA-DR3 and DR7 are in very strong linkage disequilibrium with DQw2. It is therefore possible that DQw2 is a better HLA marker for this subset of rheumatoid patients rather than the DR antigens themselves. In the present study we 
